Abstract

Introduction: COVID-19 mortality has been considerably reduced; however, diverse symptoms that persist in individuals who have been infected have highlighted the importance of a new line of care for the disease: the post-COVID-19 condition. Objectives: This review aims to contribute to the planning of sound study designs and the collection of clinical data in future studies. Methodology: This study is a narrative literature review, which used the DeCS/MeSH descriptors "Neurocovid", "Manifestations" and "Inflammation" to search the PubMed, ScienceDirect and VHL databases. Results: When analyzing the auxiliary neurological tools that were used to elucidate the NeuroCOVID clinic, three articles reported the use of neuroimaging, Magnetic Resonance Imaging (MRI) and/or Computed Tomography (CT). Of these, only two showed findings and, in most cases, they were normal. Conclusion: The study shows that certain patients who recover from COVID-19 may nevertheless have lasting neurological sequelae that may not have been considered in the acute course of the disease. Therefore, long-term monitoring of neurological deficits is fundamental in the clinical approach and may represent a better prognosis for individuals affected by the complications of neuroCOVID-19.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call